Home News NAFDAC Seizes Suspected Falsified Artemether/Lumefantrine in Kano

NAFDAC Seizes Suspected Falsified Artemether/Lumefantrine in Kano

0
NAFDAC Seizes Suspected Falsified Artemether/Lumefantrine in Kano

 

The National Agency for Food and Drug Administration and Control (NAFDAC) has seized a suspected substandard and falsified antimalarial medicine, Artemether/Lumefantrine 80mg/480mg, purportedly manufactured by Bandaram Pharma Packleh Ltd (BPPL), India.

NAFDAC disclosed this in Public Alert No. 042/2026, warning healthcare providers, importers, distributors, retailers, Patent and Proprietary Medicine Vendors (PPMVs) and the general public against the purchase, sale, supply or use of the affected product.

According to the Agency, the product was intercepted by its officials during routine Post-Market Surveillance activities at the Coordinated Wholesale Centre (CWC) in Kano State.

NAFDAC said verification confirmed that the NAFDAC Registration Number 02-3457 displayed on the product is fake and does not exist in the Agency’s registration database.
The Agency also noted that the product label does not contain information on the Marketing Authorisation Holder (MAH).

NAFDAC classified the product as a Falsified (F) Medical Product, warning that its circulation and use could result in treatment failure, worsening of malaria, development of drug resistance and other serious public health consequences.

The Agency urged healthcare professionals and members of the public to exercise caution, obtain medicines only from authorised and licensed suppliers, and carefully verify the authenticity of medicines before purchase and use.

NAFDAC also called on members of the public and healthcare professionals to report suspected sales, distribution or use of the affected product to the nearest NAFDAC office or call 0800-162-3322.